Europe's No. 1 healthcare market
Germany's healthcare market is No. 1 in Europe by market volume, patients, manufacturers and providers. The life sciences industry is driven by innovations in medical technology, pharmaceuticals, medical biotechnology and digital health.
EUR 417 billionHealthcare spending in Germany exceeded EUR 417 billion in 2020.
1,900 hospitalsMore than 1,900 hospitals operate in Germany with nearly 500,000 beds. The share of privately owned hospitals continues to rise.
7.6 million employeesWith more than 7.6 million employees, healthcare is one of the largest economic sectors in Germany.
4.5 percentThe German healthcare market grew at 4.5 percent annually over the past 5 years.
With sales of EUR 49.5 billion in 2020 the German pharmaceutical market is the largest in Europe and the fourth largest in the world.
Demographic change and technology – pushing healthcare forward
In the last 15 years, the number of people with diabetes mellitus has risen from 5.8 to 8 million people. The German market has reacted with smart solutions for diabetes management, which are expected to grow at a rate of 27 percent in the coming years.
The Digital Care Act (DVG) of 2019 provided the basis for rapidly increasing implementation of digital solutions, including electronic health records, tele-consultation, access to patient research data and the prescription of medicines app (DIGA).
And 657 biopharma compounds were in clinical development.
An ideal location for high-quality production
99% of Germany’s medtech companies are small or medium sized enterprises.
One in threemedical devices sold in Germany is less than three years old.
More than 30specialised cluster networks focusing on medical technology.
9 percentof revenue is spent on R&D.
15 percentof employees work in R&D.
European Medical ValleyOne example of an excellent innovation cluster in medical technology is the European Medical Valley in Nürnberg/Erlangen.
500 local companiesinvolved in medtech.
11 cluster staffto coordinate R&D projects and funding.
65 hospitalswith 850,000 inpatients treated in 2017.
The life sciences industries in Germany are driven by a strong and stable healthcare market, support for research and development, and a wealth of companies and institutes. Germany offers the ideal investment climate for innovation in health. Get in touch to learn more.